MSB 3.21% $1.13 mesoblast limited

MSB - Most exciting 6 months, page-139

  1. 332 Posts.
    lightbulb Created with Sketch. 17
    Regarding#7 - JCR was asked about in the analyst call. SI basically said JCR is only pursuing orphan indications and therefore won't be pursuing COVID ARDS. But SI implied discussions regarding Japan are happening.

    just speculation, but maybe a global partnership on the horizon for COVID ARDS?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.